Zenith Drugs Ltd.
ZENITHDRUG.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$696.24M
Close$
Share Statistics
| Market cap | $696.24 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (NaN%) |
| Earnings per Share | $- |
| Beta | 1.42 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zenith Drugs Ltd.
182 employees
CEO: Sandeep Bhardwaj Zenith Drugs Ltd. engages in the manufacture and trade of medicines. It offers a wide range of formulations in various forms such as ORS powder, liquid orals, ointments, liquid externals, and capsules. The company was founded by Shri Ram...